Chemokines in tumor angiogenesis and metastasis

被引:147
作者
Singh, Seema [1 ]
Sadanandam, Anguraj [1 ]
Singh, Rakesh K. [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA
关键词
chemokines; tumor growth; angiogenesis; metastasis; tumor microenvironment;
D O I
10.1007/s10555-007-9068-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chemokines are a large group of low molecular weight cytokines that are known to selectively attract and activate different cell types. Although the primary function of chemokines is well recognized as leukocyte attractants, recent evidences indicate that they also play a role in number of tumor-related processes, such as growth, angiogenesis and metastasis. Chemokines activate cells through cell surface seven trans-membranes, G-protein-coupled receptors (GPCR). The role played by chemokines and their receptors in tumor pathophysiology is complex as some chemokines favor tumor growth and metastasis, while others may enhance anti-tumor immunity. These diverse functions of chemokines establish them as key mediators between the tumor cells and their microenvironment and play critical role in tumor progression and metastasis. In this review, we present some of the recent advances in chemokine research with special emphasis on its role in tumor angiogenesis and metastasis.
引用
收藏
页码:453 / 467
页数:15
相关论文
共 209 条
[1]   Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells [J].
Aalinkeel, R ;
Nair, MPN ;
Sufrin, G ;
Mahajan, SA ;
Chadha, KC ;
Chawda, RP ;
Schwartz, SA .
CANCER RESEARCH, 2004, 64 (15) :5311-5321
[2]   The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity [J].
Addison, CL ;
Daniel, TO ;
Burdick, MD ;
Liu, H ;
Ehlert, JE ;
Xue, YY ;
Buechi, L ;
Walz, A ;
Richmond, A ;
Strieter, RM .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :5269-5277
[3]   CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells:: Clinical implications [J].
Airoldi, I ;
Raffaghello, L ;
Piovan, E ;
Cocco, C ;
Carlini, B ;
Amadori, A ;
Corrias, MV ;
Pistoia, V .
CLINICAL CANCER RESEARCH, 2006, 12 (01) :77-82
[4]   Molecular characterization of the tumor microenvironment in breast cancer [J].
Allinen, M ;
Beroukhim, R ;
Cai, L ;
Brennan, C ;
Lahti-Domenici, J ;
Huang, HY ;
Porter, D ;
Hu, M ;
Chin, L ;
Richardson, A ;
Schnitt, S ;
Sellers, WR ;
Polyak, K .
CANCER CELL, 2004, 6 (01) :17-32
[5]   The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer [J].
Arenberg, DA ;
Polverini, PJ ;
Kunkel, SL ;
Shanafelt, A ;
Hesselgesser, J ;
Horuk, R ;
Strieter, RM .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 62 (05) :554-562
[6]   Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer [J].
Arenberg, DA ;
Keane, MP ;
DiGiovine, B ;
Kunkel, SL ;
Morris, SB ;
Xue, YY ;
Burdick, MD ;
Glass, MC ;
Iannettoni, MD ;
Strieter, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03) :465-472
[7]   Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases [J].
Arenberg, DA ;
Kunkel, SL ;
Polverini, PJ ;
Morris, SB ;
Burdick, MD ;
Glass, MC ;
Taub, DT ;
Iannettoni, MD ;
Whyte, TI ;
Strieter, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :981-992
[8]   Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice [J].
Arenberg, DA ;
Kunkel, SL ;
Polverini, PJ ;
Glass, M ;
Burdick, MD ;
Strieter, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2792-2802
[9]  
Arya Manit, 2004, J Exp Ther Oncol, V4, P291
[10]   Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC [J].
Baba, M ;
Imai, T ;
Nishimura, M ;
Kakizaki, M ;
Takagi, S ;
Hieshima, K ;
Nomiyama, H ;
Yoshie, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) :14893-14898